Humatica advises Baird Capital on its investment in UGSI

ndetails

Humatica, the leading private equity specialist advisor for portfolio company organisational effectiveness, has advised Baird Capital’s private equity team on its recent investment in UGSI. UGSI is a leading provider of Water Quality Management Solutions and Chemical Feed Systems to the municipal water and wastewater utility markets. Humatica was engaged by Baird Capital to provide Organisational Due Diligence advice for this transaction.

The investment will enable the company to fuel continued growth due to the increasing prevalence of municipal water quality issues driven by climate change, increasing population density, aging infrastructure and resource scarcity.

Marcel Bättig, Humatica Partner, commented:

“Besides providing the encompassing organizational due diligence Humatica is often retained for, we also partnered with Baird to think through organizational development options for key management talent for UGSI and the future-state operating model. This to help ensure that Baird and the management team collaborate effectively from Day 1.”

Rob Ospalik, Baird Capital Partner, added:

“Humatica once again proved to be integral in carrying out the organizational due diligence on this transaction. We have partnered on several transactions over the years, and their expertise in the area of organizational effectiveness is second to none.”

The Humatica team was led by Marcel Bättig, Partner.

 

Related News

Experienced Private Equity executive Melissa Mounce joins Humatica to build the firm’s presence in the US
17 Feb., 2025 By Humatica

Experienced Private Equity executive Melissa Mounce joins Humatica to build the firm’s presence in the US

Humatica, the leading private equity specialist advisor for organizational effectiveness, is pleased to announce that Melissa Mounce has joined the firm as an Operating Partner…

Read more arrowicon
Humatica finalist for two prestigious PE Awards
03 Feb., 2025 By Humatica

Humatica finalist for two prestigious PE Awards

Humatica has been named a finalist for the Actum Awards as Value Creation Firm of the Year (People and Organisational Strategy) and for the Real Deals Private Equity Awards 2025 in…

Read more arrowicon
Humatica 2024 in Review and Outlook 2025
17 Dez., 2024 By Humatica

Humatica 2024 in Review and Outlook 2025

2024 was a milestone year for private equity, and for Humatica. The industry is under greater pressure to generate acceptable returns than ever before. With…

Read more arrowicon

Abonnieren Sie unseren monatlichen Newsletter und andere News Updates

Erhalten Sie jeden Monat Neuigkeiten und wertvolle Perspektiven zu Themen der organisatorischen Effektivität